NCT07456631 ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence
| NCT ID | NCT07456631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Coimbra |
| Condition | Social Anxiety Disorder (SAD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2023-09-01 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Social functioning, fundamental to adolescent's development and mental health, may be impaired by polarizing problematic social functioning, namely externalizing symptoms manifested by Oppositional Defiant Disorder and internalizing symptoms portrayed by Social Anxiety Disorder. Despite their high prevalence and similar associated impairments, interventions targeting these disorders are differently conceived. Alternatively, Acceptance and Commitment Therapy (ACT) proposes that those apparently dissimilar social difficulties are rooted in similar processes. Though research has shown ACTs' efficacy in changing adults' internalizing and externalizing symptoms, studies on the potential of ACT in changing those problematics in adolescence are still scarce. This project proposes to conduct three clinical trials to test the efficacy and (dis)similarities of an transdiagnostic ACT intervention for changing internalizing and externalizing symptomatology in adolescents. It will amplify the transdiagnostic and evidence-based application of ACT to adolescents presenting polarizing disorders in the social functioning spectrum.
Eligibility Criteria
Inclusion Criteria: Study I: * Main diagnosis of Oppositional Defiant Disorder (ODD) * Meeting diagnostic criteria for Social Anxiety Disorder (SAD) Study II: * Main diagnosis of Social Anxiety Disorder (SAD) * Meeting diagnostic criteria for Oppositional Defiant Disorder (ODD) Exclusion Criteria (applies to both studies): * Impaired cognitive development based on school records * Presence of psychotic symptoms according to the diagnostic interview * Diagnosis of autism spectrum disorder according to the diagnostic interview * Currently undergoing another psychological intervention for a psychiatric condition Note: Comorbid conditions other than the co-occurrence of ODD and SAD will not be considered exclusion criteria.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07456631 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Social Anxiety Disorder (SAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07456631 currently recruiting?
Yes, NCT07456631 is actively recruiting participants. Contact the research team at mfrancisca.mca@gmail.com for enrollment information.
Where is the NCT07456631 trial being conducted?
This trial is being conducted at Coimbra, Portugal.
Who is sponsoring the NCT07456631 clinical trial?
NCT07456631 is sponsored by University of Coimbra. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.